Infection with a mutated HIV strain results in better survival

Persons infected with a mutated HIV strain, transmitted from those who have the genetic advantages to control the virus, results in improved survival according to a recent study by South African researchers. The study, published March 21st in the open-access journal PLoS Pathogens, looked for genetic mutations in the infecting virus in 24 newly infected people in Durban, South Africa.

The study was conducted by CAPRISA (the Centre for the AIDS Program of Research in South Africa) researchers at the Universities of Cape Town, KwaZulu-Natal, Western-Cape and the National Institute of Communicable Diseases in South Africa. According to Professor Salim Abdool Karim, Director of CAPRISA, “It is significant that the mutations to HIV which occur in a person with advantageous genes leads to a low viral load, even when the virus infects a new person who does not have these ‘good’ genes. Low viral load is a goal of several HIV vaccines as it means that these HIV infected people will be clinically well for longer and be less likely to spread the virus.”

HLA genes affect the rate of disease progression in HIV-infected individuals, alerting the immune system to HIV’s presence. HIV can evade the immune system by mutating into forms unrecognizable by the HLA. However, it is known that some people have versions of the HLA gene (for example HLA-B*57 and HLA-B*5801) that can only be evaded by the virus if it mutates to a form that has a reduced replication rate.

In this study the researchers identified two mutations, A146X and T242N, in the Gag sequences of acutely infected HLA-B*57/5801 negative women, that were associated with lower viral loads and higher CD4+ counts in these women up to a year post-infection. Both mutations have been previously identified as HLA-B*57/5801 immune evasion mutations and T242N has been shown to compromise viral replication capacity. This study now indicates time that HLA-B*57 or HLA-B*5801 negative people who are infected by such reproductively compromised viruses may also have better survival prospects.

“Disease progression is determined by a complex interplay between the host and the virus,” says team leader Carolyn Williamson. “While the role of host genetics is well established, this study shows that genetic polymorphisms in the transmitted virus can offer survival advantage to a newly infected person.”

The possibility that an interacting network of attenuating mutations may be responsible for better long-term survival could profoundly influence our understanding of the cause and development of HIV, Williamson says. This study has implications for HIV vaccine design and immunotherapeutics.

Chopera DR, Woodman Z, Mlisana K, Mlotshwa M, Martin DP, et al. (2008) Transmission of HIV-1 CTL Escape Variants Provides HLA-Mismatched Recipients with a Survival Advantage. PLoS Pathog 4(3): e1000033. doi:10.1371/journal.ppat.1000033

Source: Public Library of Science

Related stories:

Zinc finger proteins put personalized HIV therapy within reach
Researchers at the University of Pennsylvania School of Medicine and collaborators are using minute, naturally occurring proteins called zinc fingers to engineer T cells to one day treat AIDS in humans.
New treatments for viral and other diseases by blocking genes
The elusive goal of developing effective treatments for viral diseases such as AIDS and influenza has been brought closer by dramatic progress in the ability to interfere with viral genetic machinery. The stage was set for a coordinated European effort to accelerate research and stimulate development of new treatments against viral diseases at a recent research conference organised by the European Science Foundation (ESF).
Leading HIV researchers to collaborate on vaccine development
Two global research organizations dedicated to designing a vaccine against HIV – the International AIDS Vaccine Initiative (IAVI), and the Center for HIV/AIDS Vaccine Immunology (CHAVI) – have signed an agreement to work together to address major biological questions that have slowed development of a safe, effective and affordable AIDS vaccine.
Novel mathematical model predicts new wave of drug-resistant HIV infections in San Francisco
A mathematical model shows that a new wave of drug-resistant HIV is rising among among men in San Francisco who have sex with men and that this trend will continue over the next few years, according to a new study from the UCLA AIDS Institute.
HIV isolate from Kenya provides clues for vaccine design
Two simple changes in its outer envelope protein could render the AIDS virus vulnerable to attack by the immune system, according to research from Kenya and the Fred Hutchinson Cancer Research Center published in PLoS Medicine.
Scientists Decode Genomes of Diverse TB Isolates
An international collaboration led by researchers in the US and South Africa today announced the first genome sequence of an extensively drug resistant (XDR) strain of the bacterium Mycobacterium tuberculosis, one linked to more than 50 deaths in a recent tuberculosis (TB) outbreak in KwaZulu-Natal, South Africa.
Ancient retroviruses spurred evolution of gene regulatory networks in humans and other primates
When ancient retroviruses slipped bits of their DNA into the primate genome millions of years ago, they successfully preserved their own genetic legacy. Today an estimated 8 percent of the human genetic code consists of endogenous retroviruses (ERVs)--the DNA remnants from these so-called "selfish parasites."
Emergence of recombinant forms of HIV: dynamics and scaling
The emergence of drug resistant forms of HIV often underlies the failure of current antiretroviral therapies for HIV infection. Specific mutations in the HIV genome confer resistance to individual drugs.

News discussion:

Medicine & Health news